AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pletz, M. W. R.
Right arrow Articles by Klugman, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pletz, M. W. R.
Right arrow Articles by Klugman, K. P.
Antimicrobial Agents and Chemotherapy, March 2006, p. 943-948, Vol. 50, No. 3
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.3.943-948.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Fluoroquinolone Resistance in Invasive Streptococcus pyogenes Isolates Due to Spontaneous Mutation and Horizontal Gene Transfer

M. W. R. Pletz,1,2* L. McGee,1 C. A. Van Beneden,3 S. Petit,4 M. Bardsley,5 M. Barlow,1 and K. P. Klugman1,6

Department of Global Health, Rollins School of Public Health,1 Division of Infectious Diseases, School of Medicine, Emory University,6 Respiratory Diseases Branch, Centers for Disease Control and Prevention,3 Georgia Emerging Infections Program, Atlanta, Georgia,5 Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany,2 Connecticut Department of Public Health, Hartford, Connecticut4

Received 4 July 2005/ Returned for modification 31 October 2005/ Accepted 5 December 2005

Fluoroquinolone resistance in Streptococcus pyogenes has been described only anecdotally. In this study we describe two invasive ciprofloxacin-resistant S. pyogenes isolates (ciprofloxacin MICs, 8 mg/liter), one of which shows evidence of interspecies recombination. The quinolone resistance-determining regions of gyrA and parC were sequenced. In both isolates, there was no evidence for an efflux pump and no mutation in gyrA. Both isolates had an S79F mutation in parC that is known to confer fluoroquinolone resistance. In addition, a D91N mutation in parC, which is not related to fluoroquinolone resistance but is a feature of the parC sequence of Streptococcus dysgalactiae, was found in one isolate. The parC nucleotide sequence of that isolate showed greater diversity than that of S. pyogenes. A GenBank search and phylogenetic analysis suggest that this isolate acquired resistance by horizontal gene transfer from S. dysgalactiae. Statistical testing for recombination confirmed interspecies recombination of a 90-bp sequence containing the S79F mutation from S. dysgalactiae. For the other isolate, we could confirm that it acquired resistance by spontaneous mutation by identifying the susceptible ancestor in an outbreak setting.


* Corresponding author. Mailing address: Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Phone: 49 511 532 9612. Fax: 49 511 532 3353. E-mail: pletz.mathias{at}mh-hannover.de.


Antimicrobial Agents and Chemotherapy, March 2006, p. 943-948, Vol. 50, No. 3
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.3.943-948.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.